These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 25092600)

  • 1. Familial clustering of ESRD in the Norwegian population.
    Skrunes R; Svarstad E; Reisæter AV; Vikse BE
    Clin J Am Soc Nephrol; 2014 Oct; 9(10):1692-700. PubMed ID: 25092600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. End Stage Renal Disease Predicts Increased Risk of Death in First Degree Relatives in the Norwegian Population.
    Skrunes R; Svarstad E; Reisæter AV; Marti HP; Vikse BE
    PLoS One; 2016; 11(11):e0165026. PubMed ID: 27828975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors: familial aggregation of ESRD in Europeans-is it in the genes?
    Freedman BI; Robinson TW
    Nat Rev Nephrol; 2014 Dec; 10(12):677-8. PubMed ID: 25266211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Familial Factors, Low Birth Weight, and Development of ESRD: A Nationwide Registry Study.
    Ruggajo P; Skrunes R; Svarstad E; Skjærven R; Reisæther AV; Vikse BE
    Am J Kidney Dis; 2016 Apr; 67(4):601-8. PubMed ID: 26747633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Familial aggregation of renal disease in a population-based case-control study.
    Lei HH; Perneger TV; Klag MJ; Whelton PK; Coresh J
    J Am Soc Nephrol; 1998 Jul; 9(7):1270-6. PubMed ID: 9644638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A population-based assessment of the familial component of chronic kidney disease mortality.
    Goldfarb-Rumyantzev AS; Cheung AK; Habib AN; Wang BJ; Lin SJ; Baird BC; Naiman N; Cannon-Albright L
    Am J Nephrol; 2006; 26(2):142-8. PubMed ID: 16557020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Family history of end-stage renal disease among hemodialyzed patients in Poland.
    Gumprecht J; Zychma MJ; Moczulski DK; Gosek K; Grzeszczak W
    J Nephrol; 2003; 16(4):511-5. PubMed ID: 14696752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Familial clustering of end-stage renal disease in Mississippi.
    Butkus DE
    J Miss State Med Assoc; 2002 Mar; 43(3):71-7. PubMed ID: 11944578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Family history of end-stage renal disease does not predict dialytic survival.
    Freedman BI; Soucie JM; Kenderes B; Krisher J; Garrett LE; Caruana RJ; McClellan WM
    Am J Kidney Dis; 2001 Sep; 38(3):547-52. PubMed ID: 11532687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Family Aggregation and Heritability of ESRD in Taiwan: A Population-Based Study.
    Wu HH; Kuo CF; Li IJ; Weng CH; Lee CC; Tu KH; Liu SH; Chen YC; Yang CW; Luo SF; See LC; Yu KH; Huang LH; Zhang W; Doherty M; Tian YC
    Am J Kidney Dis; 2017 Nov; 70(5):619-626. PubMed ID: 28663061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcome in biopsy-proven Lupus nephritis: Evaluation of biopsies from the Norwegian Kidney Biopsy Registry.
    Norby GE; Mjøen G; Bjørneklett R; Vikse BE; Holdaas H; Svarstad E; Aasarød K
    Lupus; 2017 Jul; 26(8):881-885. PubMed ID: 28059018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Higher risk for renal failure in first-degree relatives of white patients with end-stage renal disease: a population-based study.
    O'Dea DF; Murphy SW; Hefferton D; Parfrey PS
    Am J Kidney Dis; 1998 Nov; 32(5):794-801. PubMed ID: 9820449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term risk of ESRD in IgAN; validation of Japanese prognostic model in a Norwegian cohort.
    Bjørneklett R; Vikse BE; Bostad L; Leivestad T; Iversen BM
    Nephrol Dial Transplant; 2012 Apr; 27(4):1485-91. PubMed ID: 21821835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low birth weight increases risk for end-stage renal disease.
    Vikse BE; Irgens LM; Leivestad T; Hallan S; Iversen BM
    J Am Soc Nephrol; 2008 Jan; 19(1):151-7. PubMed ID: 18057216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Familial factors in the association between preeclampsia and later ESRD.
    Vikse BE; Irgens LM; Karumanchi SA; Thadhani R; Reisæter AV; Skjærven R
    Clin J Am Soc Nephrol; 2012 Nov; 7(11):1819-26. PubMed ID: 22956264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between attributed cause of end-stage renal disease and risk of death in Brazilian patients receiving renal replacement therapy.
    Batista PB; Lopes AA; Costa FA
    Ren Fail; 2005; 27(6):651-6. PubMed ID: 16350813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics and Outcomes of Patients With Systemic Sclerosis (Scleroderma) Requiring Renal Replacement Therapy in Europe: Results From the ERA-EDTA Registry.
    Hruskova Z; Pippias M; Stel VS; Abad-Díez JM; Benítez Sánchez M; Caskey FJ; Collart F; De Meester J; Finne P; Heaf JG; Magaz A; Palsson R; Reisæter AV; Salama AD; Segelmark M; Traynor JP; Massy ZA; Jager KJ; Tesar V
    Am J Kidney Dis; 2019 Feb; 73(2):184-193. PubMed ID: 30122544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preeclampsia and the risk of end-stage renal disease.
    Vikse BE; Irgens LM; Leivestad T; Skjaerven R; Iversen BM
    N Engl J Med; 2008 Aug; 359(8):800-9. PubMed ID: 18716297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal parenchymal area and risk of ESRD in boys with posterior urethral valves.
    Pulido JE; Furth SL; Zderic SA; Canning DA; Tasian GE
    Clin J Am Soc Nephrol; 2014 Mar; 9(3):499-505. PubMed ID: 24311709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intrauterine growth restriction, preterm birth and risk of end-stage renal disease during the first 50 years of life.
    Gjerde A; Lillås BS; Marti HP; Reisæter AV; Vikse BE
    Nephrol Dial Transplant; 2020 Jul; 35(7):1157-1163. PubMed ID: 32040151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.